Scarica l'app Stockscreener
10.50
1.87%
-0.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$10.70
Aprire:
$10.63
Volume 24 ore:
184.92K
Relative Volume:
0.46
Capitalizzazione di mercato:
$298.49M
Reddito:
$30.43M
Utile/perdita netta:
$-18.15M
Rapporto P/E:
-15.22
EPS:
-0.69
Flusso di cassa netto:
$-9.08M
1 W Prestazione:
-6.42%
1M Prestazione:
-6.50%
6M Prestazione:
-37.20%
1 anno Prestazione:
-11.62%
Intervallo 1D:
$10.48
$10.84
Intervallo di 1 settimana:
$10.06
$11.25
Portata 52W:
$9.76
$19.22
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Nome
Clearpoint Neuro Inc
Settore
Industria
Telefono
(949) 900-6833
Indirizzo
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Confronta CLPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
10.50 | 318.96M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
131.87 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.11 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
390.88 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.02 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.88 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2023-10-24 | Iniziato | Stifel | Buy |
| 2023-02-16 | Ripresa | B. Riley Securities | Buy |
| 2022-04-05 | Ripresa | B. Riley Securities | Buy |
| 2021-03-18 | Iniziato | Lake Street | Buy |
| 2020-07-17 | Iniziato | B. Riley FBR | Buy |
Mostra tutto
Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates - MSN
Will ClearPoint Neuro Inc. stock benefit from AI tech trendsJuly 2025 Review & Fast Gain Stock Tips - Newser
Why ClearPoint Neuro Inc. stock attracts strong analyst attentionWeekly Risk Summary & Accurate Intraday Trade Tips - 선데이타임즈
What makes ClearPoint Neuro Inc. stock price move sharplyJuly 2025 Setups & Capital Protection Trade Alerts - thegnnews.com
Is ClearPoint Neuro Inc. stock entering bullish territoryJuly 2025 Outlook & Daily Entry Point Alerts - Newser
Pattern recognition hints at ClearPoint Neuro Inc. upsideEarnings Beat & Technical Buy Zone Confirmation - Newser
ClearPoint Neuro outlines global expansion plans and anticipates regulatory milestones while advancing cell and gene therapy initiatives - MSN
Resistance Break Could Fuel ClearPoint Neuro Inc. RallyPortfolio Value Summary & AI Optimized Trade Strategies - sundaytimes.kr
ClearPoint Neuro: Biopharma Momentum Continues To Build - Seeking Alpha
retail investors who own 49% along with institutions invested in ClearPoint Neuro, Inc. (NASDAQ:CLPT) saw increase in their holdings value last week - simplywall.st
ClearPoint Neuro Achieves Record Revenue in Q2 2025 - The Globe and Mail
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q2 2025 Earnings Call Transcript - Insider Monkey
Retail investors account for 49% of ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) ownership, while institutions account for 42% - Yahoo Finance
ClearPoint Neuro Reports Record Q2 Revenue Growth - MSN
ClearPoint Neuro (CLPT): Navigating Growth Amid Margin Pressures—Is Now the Time to Enter? - AInvest
ClearPoint Neuro Inc (CLPT) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
ClearPoint Neuro Inc (CLPT) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
ClearPoint Neuro 2025 Q2 Earnings Wider Losses Amid Revenue Growth - AInvest
ClearPoint Neuro's Q2 2025: Key Contradictions in MRI Utilization, GLP Compliance, and Revenue Growth - AInvest
Stock Market Insights - Seeking Alpha
ClearPoint Neuro Outlines Global Expansion Plans and Advances Cell and Gene Therapy Initiatives - AInvest
Earnings call transcript: Clearpoint Neuro’s Q2 2025 earnings miss forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: Clearpoint Neuro’s Q2 2025 earnings miss forecasts - Investing.com India
ClearPoint Neuro, Inc. SEC 10-Q Report - TradingView
Clearpoint Neuro earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada
ClearPoint Neuro Q2 Loss Widens, Revenue Rises - MarketScreener
ClearPoint Neuro: Balancing Near-Term Earnings Pressure with Long-Term R&D-Driven Growth - AInvest
ClearPoint Neuro Reports Q2 2025 Record Revenue of $9.2mln, 17% YoY Increase - AInvest
ClearPoint Neuro Reports Second Quarter 2025 Results - ACCESS Newswire
ClearPoint Neuro Hits Growth Milestone with Record Q2 Revenue, Lands Major $105M Financing Deal - Stock Titan
How moving averages guide ClearPoint Neuro Inc. tradingPrice Spike Prediction for Active Traders - Newser
Is ClearPoint Neuro Inc. stock reversal real or fakeFree Day Trading Signals With High Precision - Newser
Will ClearPoint Neuro Inc. stock go up soonFree Entry Plan for Oversold Reversal Stocks - Newser
Detecting support and resistance levels for ClearPoint Neuro Inc.Trade Safety Matrix for Conservative Traders - Newser
How high can ClearPoint Neuro Inc. stock price go in 2025Free Reversal Alert Based on RSI Indicator - Newser
Chart based analysis of ClearPoint Neuro Inc. trendsFree Risk Controlled Short Term Trade Plans - Newser
Live market analysis of ClearPoint Neuro Inc.Smart Trend Analysis With Buy Point Cues - Newser
Is it too late to sell ClearPoint Neuro Inc.Support and Resistance Zone Summary Chart - Newser
Leading vs lagging indicators on ClearPoint Neuro Inc. performancePredictable Income Summary for Long-Term Trades - Newser
Is ClearPoint Neuro Inc. meeting your algorithmic filter criteriaTechnical Setup Guide for Daily Watchlist - Newser
ClearPoint Neuro (CLPT) to Release Earnings on Tuesday - Defense World
ClearPoint Neuro CLPT 2025Q2 Earnings Preview Upside Potential on Innovative Product Launch - AInvest
How ClearPoint Neuro Inc. stock performs during market volatilitySector-Wise Stock Strength Trend Analysis - Newser
Clearpoint Neuro Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛
Analyzing net buyer seller activity in ClearPoint Neuro Inc.Daily Market Momentum Summary and Strategy - Newser
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio - ACCESS Newswire
Breakthrough: US Hospitals Complete First-Ever Commercial Gene Therapy Brain Treatments for Rare Disease - Stock Titan
How does ClearPoint Neuro Inc. generate profit in a changing economyHigh-profit capital plays - Jammu Links News
What catalysts could drive ClearPoint Neuro Inc. stock higher in 2025Achieve unparalleled market performance - Jammu Links News
What are analysts’ price targets for ClearPoint Neuro Inc. in the next 12 monthsFree Trend-Following Techniques - Jammu Links News
Clearpoint Neuro Inc Azioni (CLPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Clearpoint Neuro Inc Azioni (CLPT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BURNETT JOSEPH | CEO and President |
Jun 09 '25 |
Sale |
13.29 |
21,247 |
282,373 |
243,522 |
0.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):